COMMUNIQUÉS West-GlobeNewswire

Venus Concept Announces $11.48 Million Debt-to-Equity Exchange Transaction
02/10/2025
Reduction of outstanding debt by Madryn Asset Management continues to improve the Company’s financial position TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: [...]
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
02/10/2025
FOSTER CITY, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product [...]
Cardiff Oncology to Participate in Two Upcoming Investor Conferences
02/10/2025
SAN DIEGO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced [...]
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/10/2025
SAN FRANCISCO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and [...]
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/10/2025
WALTHAM, Mass., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living [...]
BEYOND IMMORTALITY: European Wellness Biomedical Group Unveils Landmark Research on Longevity Through Cell Regeneration Over Organ Transplants
02/10/2025
From hot-mic whispers of World Leaders to groundbreaking science, Prof. Mike Chan reveals why cellular regeneration — not organ swaps, holds the key to extending human healthspan and lifespan. A Whisper in Beijing [...]
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.
02/10/2025
EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA) and LAVA Therapeutics N.V. (“LAVA”) (Nasdaq: LVTX) today [...]
CORRECTION – Algae-C Acquisition by Rockcliffe Labs
02/10/2025
TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Algae-C Inc. (“Algae-C”) today issues a correction to its earlier release announcing its acquisition by Rockcliffe Labs Inc. (“Rockcliffe Labs”). The prior release suggested [...]
Vireo Growth Inc. Enters into Definitive Agreements to Acquire Outstanding Senior Secured Convertible Notes of Schwazze
03/10/2025
– Transaction reflects continuation of Vireo’s M&A strategy and is expected to close later this month – MINNEAPOLIS, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: [...]
Cross Canada VW Van Tour Will Raise Awareness For Importance Of Natural Health Products
02/10/2025
ST. ALBERT, Alberta, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Shawn Buckley can best be described as a man on a mission, with an important message to deliver. And he is delivering that message via a 1985 Volkswagen van. The [...]
UPDATE — Pennant Completes Purchase of Tennessee, Georgia and Alabama Operations from UnitedHealth Group and Amedisys
02/10/2025
EAGLE, Idaho, Oct. 02, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announced today [...]
Oxford Treatment Center Brings Flexible Addiction Care to Southaven, Debuts Evening IOP with Public Meet-and-Greet
02/10/2025
SOUTHAVEN, Miss., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Oxford Treatment Center is expanding its outpatient services in Southaven with a new evening intensive outpatient program (IOP). The new evening program is designed to [...]
Algae-C Inc. Announces Completion of Acquisition by Rockcliffe Labs Inc.
02/10/2025
TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Algae-C Inc. (“Algae-C”) today announced that it has been acquired by Rockcliffe Labs Inc. (“Rockcliffe Labs”), a Canadian biotechnology venture creation platform. Under the [...]
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/10/2025
BOSTON, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous [...]
Cirrus Therapeutics Raises $11 M Seed Financing to Advance Novel Ocular Gene Therapy to Reverse Underlying Age-Related Cause of Dry AMD
02/10/2025
Cirrus’ lead program is a novel AAV gene therapy designed to restore IRAK-M, a central regulator of the eye’s immune homeostasis, so as to prevent AMD progression and preserve central vision IRAK-M levels decrease with [...]
A.D.A.M. Innovations Launches GeneLink, the World’s First Genetics-Powered Ad Platform
02/10/2025
TOKYO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- A.D.A.M. Innovations Co. (“A.D.A.M. Innovations”), Japan’s leading genomics and AI company, today announced the official launch of GeneLink , a breakthrough advertising platform [...]
BioStem Technologies Expands Partnership with the Florida Panthers as a Sponsor for the 13th Season of the “Heroes Among Us” Program
02/10/2025
Program has honored more than 500 members of the military since its inception Sponsorship honors both local military veterans and healthcare professionals POMPANO BEACH, Fla., Oct. 02, 2025 (GLOBE NEWSWIRE) -- BioStem [...]
AVAVA Named Winner Best Emerging Disruptor Octane High Tech Awards
02/10/2025
Innovative Focal Point Technology™ with ComfortCool™ Delivers Regenerative Aesthetic Treatments Safe for all Skin Tones—Redefining Skin Health from the Inside Out NEWPORT BEACH, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE [...]
Corey A. Collins Promoted to CEO of Tekton Research to Lead Next Era of Growth
02/10/2025
Growth Supports Tekton’s Strategic Focus in CNS and Cardiometabolic research AUSTIN, Texas, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Tekton Research, a leading multi-site clinical trial company, is pleased to announce the [...]

Pages